BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND ATP2B3, PMCA3, 492, ENSG00000067842
117 results:

  • 1. Distinct presentation of melanoma in Black patients may inform strategies to improve outcomes.
    Steadman JA; Glasgow AE; Neequaye NN; Habermann EB; Hieken TJ
    J Surg Oncol; 2024 May; 129(6):1041-1050. PubMed ID: 38436625
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Long-Term Intracranial Outcomes With Combination Dual Immune-Checkpoint Blockade and Stereotactic Radiosurgery in Patients With Melanoma and Non-Small cell Lung Cancer Brain Metastases.
    Vaios EJ; Shenker RF; Hendrickson PG; Wan Z; Niedzwiecki D; Winter SF; Shih HA; Dietrich J; Wang C; Salama AKS; Clarke JM; Allen K; Sperduto P; Mullikin T; Kirkpatrick JP; Floyd SR; Reitman ZJ
    Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1507-1518. PubMed ID: 38097090
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Rapid Passive Gamma Mapping as an Adjunct to Electrical Stimulation Mapping for Functional Localization in Resection of Primary Brain Neoplasms.
    Tan H; Nugent JG; Fecker A; Richie EA; Maanum KA; Nerison C; Bowden SG; Yaylali I; Han SJ; Colgan DD; Oken B; Raslan AM
    World Neurosurg; 2024 Jan; 181():e483-e492. PubMed ID: 37871691
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Mean global DNA methylation serves as independent prognostic marker in IDH-wildtype glioblastoma.
    Eckhardt A; Drexler R; Schoof M; Struve N; Capper D; Jelgersma C; Onken J; Harter PN; Weber KJ; Divé I; Rothkamm K; Hoffer K; Klumpp L; Ganser K; Petersen C; Ricklefs F; Kriegs M; Schüller U
    Neuro Oncol; 2024 Mar; 26(3):503-513. PubMed ID: 37818983
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The effect Of vascular related CeRNA genes and corresponding imaging biomarkers on survival in lower grade glioma.
    Guo Y; Guo H; Tong H; Xue W; Xie T; Wang L; Tong H
    Ir J Med Sci; 2024 Apr; 193(2):653-663. PubMed ID: 37801268
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identifying Treatment Resistance Related Pathways by Analyzing Serum Extracellular Vesicles of Patients With Resistant Versus Regressed Retinoblastoma.
    Manukonda R; Jakati S; Attem J; Mishra DK; Mocherla TR; Reddy MM; Gulati K; Poluri KM; Vemuganti GK; Kaliki S
    Invest Ophthalmol Vis Sci; 2023 Aug; 64(11):26. PubMed ID: 37603355
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Intracranial and Extracranial Progression and Their Correlation With Overall Survival After Stereotactic Radiosurgery in a Multi-institutional Cohort With Brain Metastases.
    Carpenter DJ; Leng J; Arshad M; Giles W; Kirkpatrick JP; Floyd SR; Chmura SJ; Salama JK; Hong JC
    JAMA Netw Open; 2023 Apr; 6(4):e2310117. PubMed ID: 37099292
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Primary Cilia Are Frequently Present in Small cell Lung Carcinomas but Not in Non-Small cell Lung Carcinomas or Lung Carcinoids.
    Shinmura K; Kato H; Kawasaki H; Hariyama T; Yoshimura K; Tsuchiya K; Watanabe H; Ohta I; Asahina E; Sumiyoshi F; Hamada K; Kawanishi Y; Kawase A; Funai K; Sugimura H
    Lab Invest; 2023 Feb; 103(2):100007. PubMed ID: 37039149
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Recurrent high grade glioma surgery with carmustine wafers implantation: a long-term nationwide retrospective study.
    Champeaux-Depond C; Jecko V; Weller J; Constantinou P; Tuppin P; Metellus P
    J Neurooncol; 2023 Apr; 162(2):343-352. PubMed ID: 36991304
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Melanoma diagnosis at a specialist dermatology practice without the use of photographic surveillance.
    Brown H; De'Ambrosis B; Yong-Gee S; Griffin A; Muir J
    Australas J Dermatol; 2023 May; 64(2):234-241. PubMed ID: 36774586
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy.
    Watson AS; Goutam S; Stukalin I; Ewanchuk BW; Sander M; Meyers DE; Pabani A; Cheung WY; Heng DYC; Cheng T; Monzon JG; Navani V
    JAMA Netw Open; 2022 Dec; 5(12):e2245596. PubMed ID: 36480204
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Elevation of circulating TNF receptor 2 in cancer: A systematic meta-analysis for its potential as a diagnostic cancer biomarker.
    Kartikasari AER; Cassar E; Razqan MAM; Szydzik C; Huertas CS; Mitchell A; Plebanski M
    Front Immunol; 2022; 13():918254. PubMed ID: 36466914
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Exploring the Correlation of Abnormal CXCL9 Expression with Immune Infiltration in Glioma and Patient Prognosis Based on TCGA and GTEx Databases.
    Liao Y; Liu B; Jin C; Liao X; Zhang Z
    J Mol Neurosci; 2022 Dec; 72(12):2413-2424. PubMed ID: 36449138
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Follow-up Schedule for Patients With Sentinel Node-negative Cutaneous Melanoma (The MELFO Study): An International Phase III Randomized Clinical Trial.
    Moncrieff MD; Bastiaannet E; Underwood B; Francken AB; Garioch J; Damude S; Heaton M; Deckers EA; Patel N; Hoekstra-Weebers JE; Hoekstra HJ
    Ann Surg; 2022 Oct; 276(4):e208-e216. PubMed ID: 35866644
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Visual outcomes and predictors in optic pathway glioma: a single centre study.
    Bowman R; Walters B; Smith V; Prise KL; Handley SE; Green K; Mankad K; O'Hare P; Dahl C; Jorgensen M; Opocher E; Hargrave D; Thompson DA
    Eye (Lond); 2023 Apr; 37(6):1178-1183. PubMed ID: 35562551
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Changes in Survival Outcomes of Patients With Neuroendocrine Neoplasms Over the Past 15 Years: A Real-World Study.
    Abdel-Rahman O; Pham TM; Pokhrel A; Ruether D; Sawyer MB
    Am J Clin Oncol; 2022 May; 45(5):208-214. PubMed ID: 35383575
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Sex-Dependent Analysis of Temozolomide-Induced Myelosuppression and Effects on Survival in a Large Real-life Cohort of Patients With Glioma.
    Zeiner PS; Filipski K; Filmann N; Forster MT; Voss M; Fokas E; Herrlinger U; Harter PN; Steinbach JP; Ronellenfitsch MW
    Neurology; 2022 May; 98(20):e2073-e2083. PubMed ID: 35351796
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Exosomal PTEN as a Predictive Marker of Aggressive Gliomas.
    Patnam S; Samal R; Koyyada R; Joshi P; Singh AD; Nagalla B; Soma MR; Sannareddy RR; Ippili K; Raju S; Boola RG; Lath R; Ranjan A; Ghosh S; Balamurugan M; Ray A; Manda SV
    Neurol India; 2022; 70(1):215-222. PubMed ID: 35263886
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Identification and validation of an epithelial mesenchymal transition-related gene pairs signature for prediction of overall survival in patients with skin cutaneous melanoma.
    Shi Y; Li Z; Zhou Z; Liao S; Wu Z; Li J; Yin J; Wang M; Weng M
    PeerJ; 2022; 10():e12646. PubMed ID: 35116193
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Incidence, and preoperative and intraoperative prognostic factors of deep venous thrombosis in patients with glioma following craniotomy.
    Shi S; Cheng J; Zhao Y; Chen W
    Clin Neurol Neurosurg; 2021 Nov; 210():106998. PubMed ID: 34739883
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.